AbbVie (ABBV) Submits Regulatory Applications to FDA and EMA for Upadacitinib in Crohn's Disease
Go back to AbbVie (ABBV) Submits Regulatory Applications to FDA and EMA for Upadacitinib in Crohn's Disease| AbbVie (NYSE: ABBV) | Delayed: 234.76 +4.75 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $235.31 | P/E | 50.92 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 7,493,109 | |||||
